Quest introduces personal health panel
January 20, 2022 -- Quest Diagnostics has introduced a new panel designed to help people keep track of 100 health-related data points to provide a personalized snapshot of their overall health. Read More
NIH announces accelerator diagnostics challenge
December 7, 2021 -- The National Institutes of Health (NIH) has announced its NIH Technology Accelerator Challenge for Maternal Health, a competition that seeks to reward the development of new maternal health diagnostics. Read More
Scientists develop portable SARS-CoV-2 sensor on a chip
November 17, 2021 -- Researchers have constructed a portable, virus-imprinted chip that detects low concentrations of SARS-CoV-2 particles in clinical samples. The chip proved to be almost 27 times more sensitive than polymerase chain reaction (PCR) tests, positioning the technology as a rapid, point-of-care test, according to research published in ACS Sensors on November 11. Read More
Sense raises $65M in series B financing
November 17, 2021 -- Sense Medicine has raised a total of $65 million in series B financing, which the company will use to bring its Veros point-of-care COVID-19 test to the U.S. market. Read More
HHS to invest $650M in rapid COVID testing
November 12, 2021 -- The U.S. Department of Health and Human Services (HHS) will invest $650 million from the American Rescue Plan to strengthen manufacturing capacity for COVID-19 diagnostic testing through rapid point-of-care molecular tests. Read More
Anavasi secures $14.9M from NIH for SARS-CoV-2 assay
November 10, 2021 -- Anavasi Diagnostics has secured $14.9 million from the U.S. National Institutes of Health (NIH) to accelerate development of its AscencioDx assay for the detection of SARS-CoV-2 infection. The award is distributed under the NIH's Rapid Acceleration of Diagnostics initiative. Read More
Thermo Fisher releases new IVD system
November 10, 2021 -- Thermo Fisher Scientific has released a new IVD system called Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR. The system is designed to support the development of assay menus and IVD testing. Read More
Diabetes testing market poised for growth
November 2, 2021 -- The diabetes testing market is anticipated to reach $18.9 billion in 2021, and technological advances in diabetes testing have led to two new areas driving that market: continuous glucose monitoring and hemoglobin A1c testing, Bruce Carlson of Kalorama Information writes. Read More
COVID-19 highlights need for at-home STI testing
October 26, 2021 -- COVID-19 has accelerated the need for the evaluation and development of self-tests and specimen self-collection for the diagnosis of sexually transmitted infections (STIs), but significant obstacles remain, according to an October 19 review in the Journal of Clinical Microbiology. Read More
NanoDx, SkyWater develop nanoscale tech for COVID testing
October 6, 2021 -- NanoDx and SkyWater are partnering to further develop and bring to market nanoscale sensor technology for rapid COVID-19, traumatic brain injury, sepsis, and stroke testing. Read More